Dharmacon in RNAi supply agreement with Bayer

Published: 12-Nov-2003

US company Dharmacon, a global supplier of innovative RNA and RNA-interference (RNAi) research products, is to supply custom siRNA reagents to Bayer Pharmaceuticals Corporation.


US company Dharmacon, a global supplier of innovative RNA and RNA-interference (RNAi) research products, is to supply custom siRNA reagents to Bayer Pharmaceuticals Corporation.

The siRNA reagents supplied to Bayer will be designed using Dharmacon's proprietary SMARTselection and SMARTpool technologies and will be among the siRNAs used by Bayer in target validation research.

Dharmacon has pioneered a custom siRNA design service that employs its proprietary SMARTselection algorithms to create potent and specific gene silencing agents that can accelerate critical investigations across a broad range of biomedical and biological research.

'The utilisation of Dharmacon's siRNA by Bayer further demonstrates the advantages of our SMART technologies for pharmaceutical research and drug discovery,' said Stephen A. Scaringe, Dharmacon founder and chief scientific officer. 'Our products enable the rapid, high throughput research that leading pharmaceutical researchers demand.'

  

You may also like